AgNovos Healthcare participates at virtual congress digital O&U 2020 on October 19th – 23rd
10/16/2020 | Events
AgNovos Healthcare will participate at the virtual congress digital O&U 2020
Keep up to date on AgNovos events and related news
10/16/2020 | Events
AgNovos Healthcare will participate at the virtual congress digital O&U 2020
4/8/2020 | News
The recently issued press release on the FDA's "Breakthrough Designation" for AgNovos' newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has generated a strong of interest in the industry and has been posted on several reputable press portals.
3/26/2020 | News
AgNovos Healthcare is pleased to announce that its newest investigational product, AGN1 Local Osteo-enhancement Procedure (LOEP) Small Volume (SV) Kit, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
2/27/2020 | Events
AgNovos Healthcare will participate in the “Alterstraumatologie Kongress” in Munich from March 19th - 20th where we will exhibit the CE-marked OSSURE LOEP kit.
2/27/2020 | Events
AgNovos Healthcare will participate in the WCO in Barcelona from April 2nd – 5th, 2020.
2/27/2020 | Events
AgNovos Healthcare will participate in the “Osteologie Kongress” in Salzburg from March 12th - 14th.